Charles Swanton, Senior Group Leader, Crick Institute
In 1976, Peter Nowell first formally described cancer as an evolutionary process. This was the beginning of the notion that […]
In a recent paper published in Nature Biomedical Engineering, researchers from Northwestern University have developed a new way to increase […]
Geneticist Dr Kat Arney brings you exclusive excerpts from her new book, Rebel Cell: Cancer, evolution and the science of […]
Bev completed a BSc in Molecular and Cellular Pathology, followed by experience in research and teaching before undertaking an MSc […]
Cancer research is constantly evolving, delivering new tools to better understand the genetic changes that drive cancer development. Thanks to […]
Spatial context matters in complex biology. From cancer prevention to cancer biology, and for both translational and clinical studies, multiomic spatial […]
It is well established that detecting and diagnosing cancer earlier significantly improves patient outcomes. Therefore, the identification of cancer biomarkers […]
Muscle invasive bladder cancer (MIBC) is an aggressive form of human bladder cancer. Little is currently known about the genetic […]
Early cancer detection significantly increases a patient’s chances of a positive outcome and can reduce treatment costs. However, current cancer […]
